B6. Following is not true about the gene mutations leading to breast carcinoma
## **Core Concept**
The question pertains to genetic mutations associated with breast carcinoma. Breast cancer can result from mutations in various genes, with **BRCA1** and **BRCA2** being the most well-known. These genes are crucial for DNA repair, particularly for repairing double-strand breaks through homologous recombination. Mutations in these genes significantly increase the risk of breast and ovarian cancers.
## **Why the Correct Answer is Right**
The correct answer relates to the specifics of gene mutations leading to breast carcinoma. Without the specific details of the options provided, we can infer that the question seeks to identify a statement that does not accurately describe the relationship between gene mutations and breast carcinoma. Typically, mutations in **BRCA1** and **BRCA2** are associated with hereditary breast and ovarian cancer syndrome. Other genes like **TP53**, **CHEK2**, and **ATM** also contribute to breast cancer risk, albeit less frequently.
## **Why Each Wrong Option is Incorrect**
- **Option A:** Without specific details, we can't directly address why A is incorrect, but if it accurately describes a known association between a gene mutation and breast carcinoma, it would be a true statement.
- **Option B:** Similarly, if B correctly identifies a gene mutation's role in breast carcinoma, it would be incorrect to say it's not true.
- **Option C:** If C accurately describes a relationship, then stating it's not true about gene mutations leading to breast carcinoma would be incorrect.
- **Option D:** Presumably, if D is the correct answer, the other options (A, B, C) would contain accurate information regarding gene mutations and breast carcinoma.
## **Clinical Pearl / High-Yield Fact**
A crucial point to remember is that **BRCA1** and **BRCA2** mutations are not only associated with an increased risk of breast cancer but also significantly increase the risk of ovarian cancer. Screening for these mutations is recommended in families with a strong history of breast and/or ovarian cancer.
## **Correct Answer: D.**